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should b; adapted to tacky&dia rate and be deli& In a~kurst~ 
but Ike ideal pacing pattern is not weil under&cd. EUective 
mtitackycerdia peciog bunt patterns include tbos nitk P k+ 
them-burst decrement (SCAN) with or without an addittooal 
witkiwbunt decrwcot (RAMP). 
Mebodr. Pmswcttve medoniaed CI(LESOY~I comearw~ of two 
aotitaekycardte p&a* etgwtthms (RAMP vs. SCAN) cm ideotteal 
klduced wtaklcd “eotrtce~ tackycerdtt we3 prfelmed. 
Rem&s. Sixty4ve venlriculu teckycardlas @wo cycle tengtk 
364 * 74 ms) fmm 37 kwa.Sive studies tl&rmed kl29 padeots 
were studled; 86% ot patients bad c&my artery d&e md 
72% were re&ieg eotkurkytkmk tkenpy at tb tkoe of study. 
Of tke 65 twkycardirr, 40 were tdmtiat pairs end 25 were 
eeWmk,r taekycnr4t-a t,atrs). to tbr @red peefng 
II has long been known that overdrive ventricular pacing is 
often effective in laminating sustained ventricula- tachycu- 
dia (1). N.-wer invertigdtional implanted entitachycardie 
devices (2.3) are capable of both antitechycardia pacing and 
shock delivery for the treatment of ventricular arrhythmias. 
The goal of therapy with wch systems is the prevention of 
shock delivery whenever feasible by means of a safe and 
effective antitachycardia pacing elgorithm. Such en algo- 
rithm wotdd limit patient discomfort, pennit enhanced bat- 
tery longevity and allow more rapid conversion to normal 
rhythm with possibly fewer sym$om~ during tachycardia 
episodes (4). Although pacing is effective, the possibility of 
inadvertent pacing-induced acceleration to ventricular fib& 
lation or failure of pacing termination requires backup de& 
brillatory capabilities in any implanted automatically acti- 
vated entitachycardii device. 
The optimal use of implanted antitachycardia devices 
requires an onderstendingofthe relative safety end efficacy 
of vaious modes of aotitachywo’ia pacing. Despite general 
agreement that the rate of such peciog should be adapted to 
Ihe prevailing tachycardiamte and be delivered in bursts (5). 
the optimal antitachycatdia pacing algorithm among the 
many available is not known. The rate of bursts of adoptive 
antitachycardii pacing can be kept constant both within and 
between bursts or may change either widdn a bars1 or 
between bunts, or both. Few studies have compared diier- 
ent algorithms in a controlled manner (6) and the best pacing 
prescription for successful antitachycardia pacing has not 
been defined. In this report, the sequence of hvo dkiuent 
antitachycerdia pacing algorithms was randomly selected 
and each algorithm was applied to the seme morphologic 
ventricular techycardia in the same patient in a crossover 
fashion. The key end points to this study were etlicacy and 
safety of antitachycerdia pacing. 
The two methods of antitachycardia pacing compared 
werean adaptive burst witkeo interbontdecrement(SCAN) 
and one rhat also had a decrement within each burst of 
antitachycard#a p cing (RAMP). 
Patients with recurrent sustained ventricular tachycardia 
or fibrillation referred for clinical electmphysiologic study at 
our institution from February 1991 to February 1992 were 
eligible for study. Any antitachycardia pacing that was 
clinically required during the invasive study was initially 
delivered according to the study protocol. This study was 
approved by the institution’s Human Subjects Review Com- 
mittee. 
The electrophysiologic study was petfomed in a coovea- 
tional fashion, with multipolar electrodes positioned in the 
right ventricle for recording and stimulating. Patients were 
randomly assigned to receive one. of the antitachycardia 
pacing algorithms and induction of ventricular tachycardia 
was attempted. Ebglbdlty for this study required induction 
of sustained monomorphic ventricular tachycardia that did 
not require prompt cardioversion and for which aatitachy- 
cardia pacing could be used. After termination of ventricular 
tachycardia, the arrhythmia was reinduced and the altcr- 
native antitachycardia pacing algorithm delivered. To be 
eligible for the main study end point, tachycardia pairs had 
tobe of identical morphology-and within 30 ms-in cycle 
length. Those tachycardias that on reinduction were of 
different cycle length and morphology, patients in whom any 
tachycardia could not be reinitiated after fust tachycardia 
termination and those who required cardioversion after the 
first tachycardia induction were analyzed separately as un- 
paired tachycardias; that is, in that group only one type of 
antitachycardia pacing algorithm was delivered per tachy- 
cardia. 
Aotitochycardin pacing algorilhms. All antitachycardia 
pacing was delivered through a customized investigational 
antitachycardia device (Selectronics model 4211). Once sta- 
ble ventricular tachycardia was initiated, the device was 
activated and therapy delivered. If ventricular tachycardia 
was still present after five pacing attempts, the alternative 
therapy was delivered. The order of therapies was reversed 
at the second ventricular tachycardia induction. If direct 
current shock was required at any point, the study was 
stopped. Throughout the study, the minimal tachycardia 
cycle length for which antitachycardia pacing could be 
delivered was set at 250 ms and the minimal pacing interval 
was set at 240 ms. The theraoies used were as follows. 
RAMP profocol (Fig. IAj. This consisted of an S-beat 
burst with the first beat to beat interval of the first attempt 
adapted to 90% of the tachycardia cycle length. Within the 8 
beats of the burst, there was a 3% decrement between each 
of the successive intervals from the beginning to the end of 
tbc burst. The interval from the last tachycardia beat to the 
first paced beat and from the first paced beat to the subse- 
quent paced beat interval was progressively decreased in 5% 
steps from% to75% ofthe tachycardiacvcle length fortbe 
first four attempts, after which the first sequence was re- 
peated. 
SCAN protocol (Fin. /If). This method also used an 
E-beat antitachycardia pacing drive with the first beat to beat 
interval initially at 96% of the tachycardia cycle length but 
with a constant interbeat interval throughout the burst. As 
for the FLAhfPaleorithm. the first heat to beat interval for the 
tint four attempL was &ogressively decreased from 90% to 
75% of the tachycardia cycle length, after which the first 
sequence was repeated. 
A pacing success was prospectively defined as temdna- 
tion of the ventricular tachycardia on the cessation of the 
antitachywd;a pacing pulse train delivery or spontaneous 
termination within 5 beats after pacing was delivered. Aoti- 
tachycardia pacing-induced tachycardia acceleration was 
defined as a decrease in ventricular tachycardia cycle length 
by >50 ms after a oacioa atteamt. Safetv of antitachvcxdia 
p&g was prospe~tive~ defined as abdeoce of either pac- 
ing-induced tachycardia acceleration or degeneration into 
ventricular fibrillation. Iaetfective antitachycardia pacing 
-*aas defined as persistence of induced tachycardia atIer all 
five pacing attempts of the given algorithm had been deliv- 
ered. 
Statistkal analysis. The goal of this study was to assess 
two forms of adaptive aoritachycardia pacing on ventricular 
tachycardia induced at the time of invasive study. The study 
end points were therefore assessed per ventricular tachycar- 
dia induced. The Student I test was used to compare means 
between groups. The McNemar test was used to compare 
differewes in the proportion of successful therapy between 
identical ventricular tachycardia pairs. The Fisher exact test 
was used to compare diierences ia the prOpOnion of suc- 
cessful therapy between nonidentical groups. Where results 
were sot significant, the beta error and statistical power 
(1 - 8) were calculated. This was defined as the certainty 
with which one can exclude the presence of a significant 
difference (at (1 = 0.05) given the hi5erences observed and 
the number of oatients studied. Unless otherwise indicated. 
all data are pr&ented as mean value ? SD. 
ReSUltS 
In the time period of this study, 139 invasive studies for 
ventricular arrhythmias were performed in I04 patients. 
Eighty-three (60%) of these studies were not amenable to 
antitachycardia pacing therapy because of rapid or polymer- 
phic ventricular tachycardia, ventricular fibrillation or non- 
inducible ventricular tachycardia. Of the remaining 57 stud- 
ies, 37 were included in this study and 20 were excluded for 
technical reasons (protocol violation in 5, equipment mal- 
function or absence in IS). A total of 65 ventricular tachy- 
cardias w:re available for analysis from those 31 separate 
invasive eiectrophysiologic studies carried out in 29 patients. 
Mean rest nuclear IeR ventricular eiection fraction was 29 * 
I I%; the mean age of the patients was 62.5 3- 12.5 years. 
Twenty-five patients had coronary artcry disease as thei 
underlying condition; of the remaining four. three had di- 
lated cardiomyopathy aad one had mitral valve prolapse. 
Mean ventricular tachycardia cycle length was 364 + 74 ms 
(164 * 8 beats%nin) among all study patients: 72% of patients 
were receiving antiarrhythmic therapy at the time of study. 
F’akd vmtrkubu twlwcardlm @ii. ZA). Ammw the 65 
tachycardias available fo; study. k~-prdrs (40 &icular 
tachycardia) met the primary study entry criteria with 
identical and reproducibly initiated ventricular lehycardia 
cycle length and morphology. These 20 ventricular tachycw 
dia F& wet-e induced in 20 dierent patients. Among these 
20 patients, 5 (included in the unpaired ventricular tachycar- 
dia group) had a d&rent ventricular tachycardia induced 
that either was not reproducible or was unstable at a 
previous venhicular tachywdia induction trial and 13 were 
Figure 1. Diam of pacing intervals lhzd ww!d be d4ivered for a 
tachycardia at a cycle length of 400 ms in eirbcr antitachyca& 
pacing mode. In both. 8 pulses of antitachywdia pacing were 
delivered. All ~ntitaEhycPrdia~ingv.~adaptedtothetachyc~dix 
cycle length WL) with both the fust initial interval and the secwd 
first coupled interval starting at 5% of tachywdia cycle length. 
The minimal pacing interval farantitachycardia pac*aUempts was 
243 ms. In both cases, up to 6, anti!zchycvdia pacing attempts 
were performed. with the fifth train beinplhe same as the Fust train. 
A, The RAMP mode, with a decrement wi;hin each burst. Each 
succcsskc heat of the g-beat train decreased by 3% of the initial 
antitachycxdis pacing interual. 8, The SCAN m&e in which all 
tachycardia intervals within a burst were identical but, as in the 
RAMP mode. the initial interval between successive bursts de- 
creased from 9% iu ,596 of the tachycwdia cycle length. 
taking antiarrhythmic medic&as at the time ventricular 
tachycardia was initiated. All but one of these medication 
regimens comprised a combination of type IA and lype 111 
antiarrhythmic medications. The mean ventricular tachycw- 
dia cycle length in this group was 388 + 74 ms. The 
ventricular tachycardia was terminated in 18 of 20 attempts 
with RAMP and in 17 of 20 attempts with SCAN (P = 0.63). 
The statistical puwerofthe cmnp&ison was 93%Ga = 0.05. 
Results were discordant in three pairs. I” two of these 
pairs, ~“ccess occurred with RAMP only but not with 
SCAN, and in one pair success occurred with SCAN only 
but nut with RAMP. In the ane RAMP antitachycardia 
pacing attempt that failed, the seccmdary SCAN method was 
successful on the first attemd. In the two SCAN attempts 
that failed. the secondary RAMP method was successfu~on 
the third attempt in one and required manual pacing conver- 
sio” in the second. 
Among the successful RAMP procedures, ventricular 
tachycardia termination required I.7 + 1.1 attempls cam- 
pared with IA + 0.7 with the SCAN antitachycardia pacing 
algorithm (p = 0.41). There were no episodes of tachycardia 
acceleration among the paired ventricular tachycardias as 
defined prospectively. One ventricular tachycardia was not 
successfuUy terminated after five attempts uf pacing termi- 
nation with either RAMP or SCAN. The venWlcular tachy 
cardia cycle length was 370 ms (162 lwdslmin) in a patient 
being treated with a combination of satalal and quinidine. 
Ventricular tachycardia was terminated with direct current 
cardioverrion. 
inductions of unpaired venlrkular Ulycardias (Fig. 28). 
Twenty-live ventricular tachycardias in 17 studies from 13 
patients cauld not be studied as identical pairs and were 
treated with either the RAMP or SCAN antitachycardia 
pacing protocol. All but two of these studies were conducted 
with the patient taking no antiarrhythmic medications. 
Among the 17 studies, 8 ventricular rachycardii pairs 
(16 tachycardias) were >30_ms different in cycle length in 
8 studies, 2 ventricular tachycardias could not be reinitiated 
in 2 sludies and 2 ventricular tachycardias accelerated uring 
an antitachycardia pacing algorithm requiring direct current 
cardiaversion in 7 studies. Multiple inducrions of dierent 
cycle length ventricular tachycaniia were induced in Rve 
patients in this group, who demonstrated I3 ventricular 
tachycardias over nine invasive studies. In the remaining 
eigh1 patients, I2 ve”tricu!ar tachycardias were induced in 
eight invasive studies. 
Among these 25 ventriculartachycardias, II were treated 
with RAMP, with success occurring in eight attempts. Suc- 
cessful conversion required 1.4 t 0.7 attempts. Among the 
three RAMP failures, two ventricular tachycardias acceler- 
ated and one tachywdia was manually terminated. 
Among the 14 of the 25 unpaired ventricular lachycardias 
treated with the SCAN mode, treatment was successful in 8 
(p = 0.68 compared whh RAMP). The statistical power of 
the comparison was 88% at LII = 0.05. Acceleration occurred 
in 7 of ‘25 unpaired tachycardias during antitachycardia 
F@e 2. Resultsof antitachywdiapscing. A. Amuagthe 2Opaifad 
ventricular lachycmdiar, a” arcckratioa ‘ups seen with either 
mods: RAMP and SCAN suoccls owmcd in W% and 85%. 
resp&v~ly @ = 0.63, power = 93%). B, Of the 25 unpaired 
ventricular lachycardias, 11 were tenaiwcd using ths RAMP 
protocol (success ra,c 73%). wilh taehycardk accclcmdon in 18%. 
Fourteen taehycardks were sWlied wilh the SCAN protocol. with a 
514bsucce~ssnda369baccekrafion te@= 0.68RAMPvs. SCAN 
wxew, powa = 88%, p = 0.41 for accckmtion ia RAW YS. 
SCAN). C, In all ventrkular tachycardks studkd. 31 were assessed 
with the RAMP prutoeol Wccess rata 84%) with accekratiun 
in 6%, and 34 vcrc sltied with the SCAN pmtccol kucceu rate 
75%) with acceleration i  IS% (p = 0.31 RAMl’vs. SCAN success. 
power = 8196, p = 0.43 for accelemtiw in RAMP YE. SCAN). See 
text for discussion. 
pacing attempts (2 RAMP, 5 SCAN p = 0.W 1 of which 
was accomwniad by pacing terminrdicm. 
Among ‘ill 65 venttiad~ tachycardia episades available 
for analysis. pacing termination occurred in 37 (78%) and 
tachycardiaacceleratian occurred in 7(11%) (Fig. 20 Mean 
:achycardia cycle length of pacing te;;;iina:ed veotrico!a: 
tachycardia was 378 t 69 ms compared with 324 I 58 among 
those not terminated by wine, lo = 0.035). With one 
exception, the faster t&y&d& that were not terminated 
by pacing were also those in which pacing induced acceler- 
ation. There was no difference in ejection fraction between 
patients with tachycardias that were or were not terminated 
by pacing. 
Discus&m 
The chief finding of this study is that two diierent 
algorithms for pacing termination of induced ventricular 
tachycerdia have similar enicacy and safety. 
Riorstodies. The choice of optimal antitachycxdia pat- 
ing algorithms has had limited study in B prospective coo- 
trolled fashion. In sopraventricular tachycardias, it has been 
suggested that an aotiiachycardia pacing algorithm that 
consists of scanning without an intnbunt decrement is 
superior to one thar has this decrement (7). In ventricular 
tachycardia. one study (6) found a within-hunt adaptive 
decrement o be superiorto one with B tixed burst adapted to 
cycle length at the initial attempt and then repeated. Other 
&lies (i.9) of nonidentical vebtricolar tach&&w found 
no difference in rliicacy between two adaptive protocols 
with or without an intmbunt decrement. 
The efficacy of antitachycardia pacing has traditionally 
been explained by its e&t on the reentraot circuit that 
supports most ventricular tachycardias. Pacing termination 
is presumed to occur whenever a critical component of the 
reentrant circuit is made refractory to successive depolar- 
izdiin by the propz&ng tachycardia wave fmnt (IO). 
Changes in tachycardia cycle length may occur during the 
rhythm episode (Ill: Iherefore, aotitachyeardia pacing that 
is adapted to the sensed tachycardia cycle length is thought 
to be superior to pacing modes with predetermined and fixed 
coupling intervals or cycle length. The principle that the 
excitable gap for tenoination of a tachycardia may change 
has led to the advocacy of pmssively longer trains of 
paced beats with a within-burst decrement (12). However, 
once trains ofextrastimuli are adapted to the prevailing cycle 
length, there is tto clear evidence for the superiority of one 
type of antitachycardia pacittg burst to another. and we 
observed no significant difference between the two algo- 
rithms examined io this study. 
Reseat stody, Adapted aotitachycardia pacing can vary 
in burst duration and pattern. In this study, we compared 
only the latter and chose an S-beat burst duration. Although 
this pmdxed a safe and effective aotitachycardia pacing 
algorithm, the optimal duration of the drive train is not 
known. Longer bursts may be related to pacing-induced 
acceleration, especially ifcoexisting with an intmborst dec- 
rement (13). The optimal rate of bursts relattve to ventricular 
tachycaniia cycle length has oa been extensively investi- 
gated. Our results suggest that antitachycanlia pacing is 
usually et&ctive at 80% to 913% of tachycardia cycle length. 
In view of the theoretic risk that faster p&g inc:eases the 
risk of acceleration. limiting the pacing rate to 75% of 
ventricular tachycardia cycle length seems an acceptable 
compromise between efficacy and safety. 
Although the cycle length of induced ventricular tachy- 
cardia was strongly correlated with a successful antitachy- 
cardn pacing ootcome, there was a considerable overlap 
between cycle lengths of soccessiid and unsuccessful anti- 
tachycardia pacing. Our findings underscore Ihc reqoirement 
that aorilachycardia pacing must always be petformed with 
backup defibrillatory capabiities. Pac&induced tachycar- 
dia acceleration occurred in II% of all antitachycardia 
pacing attempts. always in huter tacbycardias. Because 
antitacbycwtiia pacing eilicacy is cycle Ieogth dependeot, 
our study tended to focus on ventricular tacbycardias with 
generally slower cycle lengths induced during medical ther- 
apy. Our results suggest that aotiorrhytbmic drugs may be 
useful adjuncts to treatment with aotitachycardia pacing 
devices. decreasing the need for shock delivery. 
Our results also suggest that antitachycanlia pacing efli- 
cacy is not dependent on burst pattern and may be a 
statistical probability function related most critically to 
tachycardia rate. The importance of tachycardia rate in 
establishing effective ootitachycardia pacing has been noted 
previously (14.15). In this study. effective antitachycardia 
pacing occurred within three attempts io all caes. These 
results imply that if rapid establishment of normal rhythm is 
not achieved within a few attempts of delivery of any 
adaptive antitachycwdia paciog algorithm. prompt pro&es- 
sion to alurnative therapy should be considered. 
Sludy limitations. This study was a short-term study in 
sedated patients. Such studies may oat predict long-term 
efficacy of any type of eotitachycardia pacing (16.17). An 
attempt wits made to obviate some of the factcfs that can 
a&t ventricular tachywdia and its termination by exam- 
ining identical rate and momhologic tachycudias io a prc- 
&live fashion. Nonethele& 25if 65 e&odes of w&C- 
ular tachycard.ia could not be assessed as identical pairs. 
However, the results in this groop were the same as those in 
the matched pairs, except for a lower success i-ate that was 
associated with faster ventricular tachycardia rates in un- 
paired tachycardias. The study was limited by design to 
patients with orgaoized and reasonably well tolerated WI- 
tricolar tachycardia. Although this allows a diict campari- 
son between two different atttitachycardia pacing methods, 
our design may limit the ability to generalize our results to 
all patients with ventricular tacbycardia. All cases of pacing- 
induced tachycardia acceleration and most failores of aoti- 
tachycadia pacing occurred in patients in the unpaired 
ventricular t&hycardia group, who generally were not 
takine aotiarrhvthmic drons and tended lo have faster ven- 
triC&r tachyc’ardii than those of patients in the paired 
venlricolar Iachycardia group. Overall, 72% of induced 
ventricular tacbycardias occurred in patients taking anti- 
arrhythmic medications. Although this finding may limit the 
utility of our results, it may indicate the type of patients who 
mzy be candidates for antitachycardia pacing as part of a 
tiered approach to device therapy. In one study (4), 35% of 
patients receiving an investigational tiered system were on 
antianhythmic medication that presumably slowed ventric~ 
ular tachycardia or allowed antitachycardia pacing to occur. 
In that study, use of antitachycardia pacing allowed a 
decrease in the requirement for shock delivery. 
Conclusions. When antitachycardia pacing was delivered 
in an adaptive fashion to detected tachycardia cycle length, 
antitachycardia pacing WBS effective in 78% of induced 
ventriculw tachywdias. Successful antilachycardia pacing 
was determined by the induced techycardia cycie lenah and 
WBS wt influenced by whether the antitachycardia pacing 
bunts had a decrement within each burst. 
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